Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53

被引:32
|
作者
Loging, WT [1 ]
Reisman, D [1 ]
机构
[1] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA
基金
美国国家卫生研究院;
关键词
mutant p53; gene expression; TIMP-3; tumor suppressor;
D O I
10.1038/sj.onc.1203135
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 gene is a tumor suppressor that regulates the expression of genes required for cell cycle arrest or apoptosis. Mutations in p53 have been observed in over 60% of all human cancers. Certain classes of mutant p53 proteins maintain some of their activities or acquire novel activities and thus may contribute to the transformed phenotype. By carrying out an analysis of differential gene expression using cDNA expression arrays, we compared the expression patterns of cells expressing no p53 to isogenic lines expressing the codon 248 Arg to Trp mutant p53 allele (R248W). In this report, we show that the R248W and D281G p53 mutants, two of the more commonly occurring mutations, as well as wild type p53, repress transcription of the tissue inhibitor of metalloproteinases type 3 (TIMP3) gene by greater than tenfold. TIMP3 expression has been observed to be repressed in many tumors and its reduced expression is thought to contribute to tumor metastasis and invasiveness by allowing increased activity of metalloproteinases in the extracellular matrix. Since mutant forms of p53 tend to be expressed at greatly elevated levels in many human tumors, the retention of their ability to repress TIMP3 illustrate one mechanism by which mutant forms of the p53 gene may contribute to tumorigenesis.
引用
收藏
页码:7608 / 7615
页数:8
相关论文
共 50 条
  • [1] Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53
    W Troy Loging
    David Reisman
    [J]. Oncogene, 1999, 18 : 7608 - 7615
  • [2] Modulation of gene expression by tumor-derived p53 mutants
    Scian, MJ
    Stagliano, KER
    Ellis, MA
    Hassan, S
    Bowman, M
    Miles, MF
    Deb, SP
    Deb, S
    [J]. CANCER RESEARCH, 2004, 64 (20) : 7447 - 7454
  • [3] THE P53 TUMOR SUPPRESSOR GENE
    LEVINE, AJ
    MOMAND, J
    FINLAY, CA
    [J]. NATURE, 1991, 351 (6326) : 453 - 456
  • [4] TUMOR SUPPRESSOR P53 - ANALYSIS OF WILD-TYPE AND MUTANT P53 COMPLEXES
    MILNER, J
    MEDCALF, EA
    COOK, AC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) : 12 - 19
  • [5] P53 TUMOR SUPPRESSOR GENE
    SOUSSI, T
    [J]. BULLETIN DU CANCER, 1993, 80 (02) : 96 - 101
  • [6] Characterization of a putative p53 binding site in the promoter of the mouse tissue inhibitor of metalloproteinases-3 (TIMP-3) gene: TIMP-3 is not a p53 target gene
    Bian, JH
    Jacobs, C
    Wang, YL
    Sun, Y
    [J]. CARCINOGENESIS, 1996, 17 (12) : 2559 - 2562
  • [7] Engineered four-stranded coiled coil substitutes for the tetramerization domain of wild-type p53 and alleviates transdominant inhibition by tumor-derived p53 mutants
    Waterman, MJF
    Waterman, JLF
    Halazonetis, TD
    [J]. CANCER RESEARCH, 1996, 56 (01) : 158 - 163
  • [8] P53 - A TUMOR-SUPPRESSOR GENE
    WUSTROW, TPU
    [J]. HNO, 1993, 41 (05) : A12 - A13
  • [9] P53 - THE ULTIMATE TUMOR SUPPRESSOR GENE
    OREN, M
    [J]. FASEB JOURNAL, 1992, 6 (13): : 3169 - 3176
  • [10] THE P53 TUMOR-SUPPRESSOR GENE
    LEVINE, AJ
    CHANG, AW
    DITTMER, D
    NOTTERMAN, DA
    SILVER, A
    THORN, K
    WELSH, D
    WU, M
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 123 (06): : 817 - 823